Zhenxiang Yu

Department of Respiratory Medicine, The First Hospital of Jilin University

Affiliated withThe First Hospital of Jilin University

Research Area

Biography

Zhenxiang Yu has not added Biography.
If you are Zhenxiang Yu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells. Journal of thoracic disease\| PubMed ID: 25922718	2015
Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways. International journal of biological sciences\| PubMed ID: 26722219	2016
TRIM65 negatively regulates p53 through ubiquitination. Biochemical and biophysical research communications\| PubMed ID: 27012201	2016
p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2. Biochemical and biophysical research communications\| PubMed ID: 28392396	2017
Mucoepidermoid Carcinomas Presented as Lobar Pneumonia. Chinese medical journal\| PubMed ID: 29271391	2018
Primary Pulmonary Germ Cell Tumor with Bone Metastasis. Chinese medical journal\| PubMed ID: 29483402	2018
Influence of Air Pollution on Hospital Admissions in Adult Asthma in Northeast China. Chinese medical journal\| PubMed ID: 29692372	2018
A Challenge: Pulmonary Sclerosing Haemangioma. Chinese medical journal\| PubMed ID: 30147108	2018
Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells. Biochemical and biophysical research communications\| PubMed ID: 30454706	2018
Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus. Journal of diabetes research\| PubMed ID: 30533447	2018
Lipid metabolism participates in human membranous nephropathy identified by whole-genome gene expression profiling. Clinical science (London, England : 1979)\| PubMed ID: 31160422	2019
Decreased number of CD19CD24CD38 regulatory B cells in Diabetic nephropathy. Molecular immunology\| PubMed ID: 31181422	2019
Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer. Cancer cell international\| PubMed ID: 31346319	2019
Increased Non-switched Memory B Cells are Associated with Plasmablasts, Serum IL-6 Levels and Renal Functional Impairments in IgAN Patients. Immunological investigations\| PubMed ID: 31670996	2020
Role of Astrocytes in Post-traumatic Epilepsy. Frontiers in neurology\| PubMed ID: 31798512	2019
Combined strategy of blending and surface modification as an effective route to prepare antifouling ultrafiltration membranes. Journal of colloid and interface science\| PubMed ID: 33450453	2021
Discovery and Verification of Key Liver Cancer Genes and Alternative Splicing Events Based on Second-Generation Sequencing Data Analysis. Biological & pharmaceutical bulletin\| PubMed ID: 34602553	2021
Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects. Expert opinion on investigational drugs\| PubMed ID: 34654349	2021
Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors. Frontiers in pharmacology\| PubMed ID: 35082668	2021
Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy. Frontiers in pharmacology\| PubMed ID: 35082681	2021
Molecular Cloning and Characterization of a Novel Exo-β-1,3-Galactanase from sp. 68. Journal of microbiology and biotechnology\| PubMed ID: 35879293	2022
Efficacy analysis of targeted nanodrug for non-small cell lung cancer therapy. Frontiers in bioengineering and biotechnology\| PubMed ID: 36425650	2022